Observational studyScientific reports2025
Quantification of hounsfield unit difference in heterogeneous hematoma predicts poor functional outcomes in acute intracerebral hemorrhage.
Observational study in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05548530 (Analysis of Related Factors of Hematoma Morphology in Patients With Cerebral Hemorrhage and Prognosis Analysis of Different Regimens for Cerebral Hemorrhage), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Analysis of Related Factors of Hematoma Morphology in Patients With Cerebral Hemorrhage and Prognosis Analysis of Different Regimens for Cerebral Hemorrhage
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Heterogeneous hematoma exhibiting a blend sign undergo dynamic changes associated with neurological injury. This study quantified hyperdense and hypodense regions of blend sign on serial non-contrast computed tomography (NCCT) using ITK-SNAP, calculated the mean hounsfield unit (HU) difference (dHU), and evaluated its prognostic value in 261 patients with intracerebral hemorrhage (ICH). All patients underwent baseline CT within 6 h of symptom onset and follow-up CT within 24 h. Logistic regression and ROC analysis showed that a higher dHU was independently associated with secondary neurological deterioration, 30-day mortality, and poor 3-month functional outcomes. A dHU > 3.25 predicted poor prognosis with good specificity (AUC 0.707, P < 0.001). These findings suggest that the dHU of heterogeneous hematoma based on serial CT scans is independently associated with poor outcomes after acute ICH.Trial registration: https://ClinicalTrials.gov , NCT05548530.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.